These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 38973261)

  • 1. Receptor tyrosine kinase-like orphan receptor serves as a potential target in cancer immunotherapy.
    Wang J; Li Z; Zhao Q
    J Leukoc Biol; 2024 Jul; ():. PubMed ID: 38973261
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of the Ror family receptors in Wnt5a signaling.
    Kamizaki K; Minami Y; Nishita M
    In Vitro Cell Dev Biol Anim; 2024 May; 60(5):489-501. PubMed ID: 38587578
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ror family receptor tyrosine kinases regulate the maintenance of neural progenitor cells in the developing neocortex.
    Endo M; Doi R; Nishita M; Minami Y
    J Cell Sci; 2012 Apr; 125(Pt 8):2017-29. PubMed ID: 22328498
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Receptor tyrosine kinase-like orphan receptor 1: a novel target for cancer immunotherapy.
    Shabani M; Naseri J; Shokri F
    Expert Opin Ther Targets; 2015 Jul; 19(7):941-55. PubMed ID: 25835638
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapeutic approaches for targeting receptor tyrosine kinase like orphan receptor-1 in cancer cells.
    Kamrani A; Mehdizadeh A; Ahmadi M; Aghebati-Maleki L; Yousefi M
    Expert Opin Ther Targets; 2019 May; 23(5):447-456. PubMed ID: 30935250
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic value of receptor tyrosine kinase-like orphan receptor (ROR) family in cancer: A meta-analysis.
    Saleh RR; Antrás JF; Peinado P; Pérez-Segura P; Pandiella A; Amir E; Ocaña A
    Cancer Treat Rev; 2019 Jul; 77():11-19. PubMed ID: 31174180
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression and function of the Ror-family receptor tyrosine kinases during development: lessons from genetic analyses of nematodes, mice, and humans.
    Yoda A; Oishi I; Minami Y
    J Recept Signal Transduct Res; 2003 Feb; 23(1):1-15. PubMed ID: 12680586
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Perspectives on the development of antibody-drug conjugates targeting ROR1 for hematological and solid cancers.
    Peng H
    Antib Ther; 2021 Oct; 4(4):222-227. PubMed ID: 34805745
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ROR1 and ROR2-novel targets for neuroblastoma.
    Dave H; Butcher D; Anver M; Bollard CM
    Pediatr Hematol Oncol; 2019 Sep; 36(6):352-364. PubMed ID: 31441359
    [No Abstract]   [Full Text] [Related]  

  • 10. Targeting ROR1 identifies new treatment strategies in hematological cancers.
    Karvonen H; Niininen W; Murumägi A; Ungureanu D
    Biochem Soc Trans; 2017 Apr; 45(2):457-464. PubMed ID: 28408486
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ROR1, an embryonic protein with an emerging role in cancer biology.
    Borcherding N; Kusner D; Liu GH; Zhang W
    Protein Cell; 2014 Jul; 5(7):496-502. PubMed ID: 24752542
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Insight into the role of Wnt5a-induced signaling in normal and cancer cells.
    Endo M; Nishita M; Fujii M; Minami Y
    Int Rev Cell Mol Biol; 2015; 314():117-48. PubMed ID: 25619716
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ROR-Family Receptor Tyrosine Kinases.
    Stricker S; Rauschenberger V; Schambony A
    Curr Top Dev Biol; 2017; 123():105-142. PubMed ID: 28236965
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ROR1 and ROR2 in Human Malignancies: Potentials for Targeted Therapy.
    Rebagay G; Yan S; Liu C; Cheung NK
    Front Oncol; 2012; 2():34. PubMed ID: 22655270
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-ROR1 CAR-T cells: Architecture and performance.
    Osorio-Rodríguez DA; Camacho BA; Ramírez-Segura C
    Front Med (Lausanne); 2023; 10():1121020. PubMed ID: 36873868
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative genomics on ROR1 and ROR2 orthologs.
    Katoh M; Katoh M
    Oncol Rep; 2005 Nov; 14(5):1381-4. PubMed ID: 16211313
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Armored TGFβRIIDN ROR1-CAR T cells reject solid tumors and resist suppression by constitutively-expressed and treatment-induced TGFβ1.
    Tran TM; Chand Thakuri BK; Nurmukhambetova S; Lee JJ; Hu P; Tran NQ; Steimle B; Dash P; Schneider D
    J Immunother Cancer; 2024 Apr; 12(4):. PubMed ID: 38609317
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diverse roles for the ror-family receptor tyrosine kinases in neurons and glial cells during development and repair of the nervous system.
    Endo M; Minami Y
    Dev Dyn; 2018 Jan; 247(1):24-32. PubMed ID: 28470690
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antiproliferative and Apoptotic Effects of Novel Anti-ROR1 Single-Chain Antibodies in Hematological Malignancies.
    Aghebati-Maleki L; Younesi V; Baradaran B; Abdolalizadeh J; Motallebnezhad M; Nickho H; Shanehbandi D; Majidi J; Yousefi M
    SLAS Discov; 2017 Apr; 22(4):408-417. PubMed ID: 28328317
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Unlocking the potential: advancements and future horizons in ROR1-targeted cancer therapies.
    Li L; Huang W; Ren X; Wang Z; Ding K; Zhao L; Zhang J
    Sci China Life Sci; 2024 Aug; ():. PubMed ID: 39145866
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.